| Role of glutathione in cancer: from mechanisms to therapies L Kennedy, JK Sandhu, ME Harper, M Cuperlovic-Culf Biomolecules 10 (10), 1429, 2020 | 555 | 2020 |
| Cell culture metabolomics: applications and future directions M Čuperlović-Culf, DA Barnett, AS Culf, I Chute Drug discovery today 15 (15-16), 610-621, 2010 | 273 | 2010 |
| Machine learning methods for analysis of metabolic data and metabolic pathway modeling M Cuperlovic-Culf Metabolites 8 (1), 4, 2018 | 159 | 2018 |
| MetaboHunter: an automatic approach for identification of metabolites from 1H-NMR spectra of complex mixtures D Tulpan, S Léger, L Belliveau, A Culf, M Čuperlović-Culf BMC bioinformatics 12, 1-22, 2011 | 133 | 2011 |
| Synthesis and structure–activity relationship of 1-and 2-substituted-1, 2, 3-triazole letrozole-based analogues as aromatase inhibitors J Doiron, R Richard, MM Touré, N Picot, R Richard, M Čuperlović-Culf, ... European journal of medicinal chemistry 46 (9), 4010-4024, 2011 | 101 | 2011 |
| Clustering methods for microarray gene expression data N Belacel, Q Wang, M Cuperlovic-Culf Omics: a journal of integrative biology 10 (4), 507-531, 2006 | 95 | 2006 |
| Fuzzy J-Means and VNS methods for clustering genes from microarray data N Belacel, M Čuperlović-Culf, M Laflamme, R Ouellette Bioinformatics 20 (11), 1690-1701, 2004 | 95 | 2004 |
| 1H NMR metabolomics analysis of glioblastoma subtypes: correlation between metabolomics and gene expression characteristics M Cuperlovic-Culf, D Ferguson, A Culf, P Morin, M Touaibia Journal of Biological Chemistry 287 (24), 20164-20175, 2012 | 80 | 2012 |
| Carbohydrate microarrays: survey of fabrication techniques AS Culf, M Cuperlovic-Culf, RJ Ouellette OMICS: A Journal of Integrative Biology 10 (3), 289-310, 2006 | 78 | 2006 |
| Cancer systems biology E Wang CRC Press, 2010 | 77 | 2010 |
| Molecular method for diagnosis of colon cancer N Belacel, M Cuperlovic-Culf, R Quelette US Patent App. 11/508,244, 2008 | 71 | 2008 |
| Influence of HEK293 metabolism on the production of viral vectors and vaccine E Petiot, M Cuperlovic-Culf, CF Shen, A Kamen Vaccine 33 (44), 5974-5981, 2015 | 68 | 2015 |
| Metabolic biomarker panels of response to fusarium head blight infection in different wheat varieties M Cuperlovic-Culf, L Wang, L Forseille, K Boyle, N Merkley, I Burton, ... PLoS One 11 (4), e0153642, 2016 | 59 | 2016 |
| Human Pax-5 C-terminal isoforms possess distinct transactivation properties and are differentially modulated in normal and malignant B cells GA Robichaud, M Nardini, M Laflamme, M Cuperlovic-Culf, RJ Ouellette Journal of Biological Chemistry 279 (48), 49956-49963, 2004 | 58 | 2004 |
| Relative ratios of human seasonal coronavirus antibodies predict the efficiency of cross-neutralization of SARS-CoV-2 spike binding to ACE2 Y Galipeau, V Siragam, G Laroche, E Marion, M Greig, M McGuinty, ... EBioMedicine 74, 2021 | 55 | 2021 |
| Determination of tumour marker genes from gene expression data M Cuperlovic-Culf, N Belacel, RJ Ouellette Drug discovery today 10 (6), 429-437, 2005 | 53 | 2005 |
| Small head-to-tail macrocyclic α-peptoids AS Culf, M Cuperlovic-Culf, DA Leger, A Decken Organic letters 16 (10), 2780-2783, 2014 | 51 | 2014 |
| Investigating a signature of temozolomide resistance in GBM cell lines using metabolomics PD St-Coeur, JJ Poitras, M Cuperlovic-Culf, M Touaibia, PJ Morin Journal of Neuro-oncology 125, 91-102, 2015 | 50 | 2015 |
| Applied metabolomics in drug discovery M Cuperlovic-Culf, AS Culf Expert opinion on drug discovery 11 (8), 759-770, 2016 | 48 | 2016 |
| NMR metabolic analysis of samples using fuzzy K‐means clustering M Čuperlović‐Culf, N Belacel, AS Culf, IC Chute, RJ Ouellette, IW Burton, ... Magnetic Resonance in Chemistry 47 (S1), S96-S104, 2009 | 47 | 2009 |
Nabil Belacel, Ph.D.National Research Council of CanadaVerified email at nrc.gc.ca
